By Counterforce Health Team in Kesimpta (ofatumumab) —

How to Get Kesimpta (Ofatumumab) Covered by Cigna in New Jersey: Timeline, Appeals, and Approval Scripts

Answer Box: Getting Kesimpta Covered by Cigna in New Jersey

Cigna requires prior authorization for Kesimpta (ofatumumab) and typically responds within 5 business days. To get approval, you need: (1) a confirmed relapsing MS diagnosis, (2) prescription from an MS specialist or neurologist, and (3) baseline safety labs. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) offers free external review with a 50% success rate. Start today: Have your neurologist submit the PA through Cigna's provider portal with complete clinical documentation.

Table of Contents

  1. What Affects Kesimpta Approval Timeline
  2. Pre-Submission Preparation (0-2 Days)
  3. Submission to Initial Review (1-5 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window and Outcomes
  6. If Denied: New Jersey Appeal Process
  7. Annual Renewal Cycles
  8. Timeline Visual and Milestones
  9. Time-Saving Tips for Faster Approval
  10. Common Denial Reasons and Solutions
  11. Costs and Patient Assistance
  12. FAQ

What Affects Kesimpta Approval Timeline

Several factors influence how quickly Cigna processes your Kesimpta prior authorization:

Benefit Structure: Cigna typically manages specialty drugs like Kesimpta through Express Scripts and their specialty pharmacy network, Accredo. This adds coordination time but provides dedicated MS medication expertise.

Documentation Completeness: Cigna's approval criteria require specific elements. Missing any component triggers additional information requests that can delay approval by 1-2 weeks.

Specialist Involvement: Cigna requires prescriptions from or in consultation with a neurologist or MS specialist. General practitioners cannot independently prescribe Kesimpta, which can delay the process if specialist coordination is needed.

New Jersey Regulations: Under New Jersey law, Cigna must respond to prior authorization requests within 9 calendar days for non-urgent requests (effective 2025) and 72 hours for urgent cases.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before your neurologist submits the prior authorization, gather:

Clinical Requirements:

  • ✅ Confirmed relapsing MS diagnosis with ICD-10 code (G35)
  • ✅ MRI reports showing disease activity or progression
  • ✅ Current EDSS (Expanded Disability Status Scale) score
  • ✅ Documentation of MS phenotype (relapsing-remitting, secondary progressive with relapses, or clinically isolated syndrome)

Safety Screening Results:

  • ✅ Complete blood count with lymphocyte count
  • ✅ Liver function tests
  • ✅ Hepatitis B screening (HBsAg, anti-HBc, anti-HBs)
  • ✅ Pregnancy test if applicable
  • ✅ Vaccination history (live vaccines must be completed before starting)

Provider Information:

  • ✅ Neurologist or MS specialist contact information
  • ✅ Current Cigna member ID and policy details
  • ✅ Preferred specialty pharmacy (typically Accredo)
Tip: Request all lab results and imaging reports from your MS clinic 1-2 weeks before your appointment to avoid delays.

Submission to Initial Review (1-5 Days)

How Cigna Processes Kesimpta Requests

Your neurologist submits the prior authorization through:

  • Cigna Provider Portal (fastest option)
  • CoverMyMeds electronic system
  • Fax: (verify current number with Cigna)
  • Phone: For urgent requests requiring 72-hour turnaround

Cigna's standard response timeline is 5 business days for routine requests. New Jersey law requires decisions within 9 calendar days starting in 2025.

What Reviewers Check First

Cigna's utilization management team verifies:

  1. Age requirement: Patient must be 18 years or older
  2. Diagnosis confirmation: Relapsing form of multiple sclerosis documented
  3. Prescriber credentials: Neurologist or MS specialist involvement confirmed
  4. Safety screening: Required labs completed and within acceptable ranges

Additional Information Requests (1-7 Days)

If Cigna requests additional information, you have 3 calendar days to respond under New Jersey regulations, or the request may be automatically withdrawn.

Common Information Requests

Clinical Clarification:

  • More detailed MS phenotype documentation
  • Clarification of relapse history and frequency
  • Additional MRI findings or progression markers

Safety Documentation:

  • Updated hepatitis B screening if results are older than 6 months
  • Confirmation of completed vaccinations
  • Pregnancy counseling documentation for women of childbearing age

How to Respond Quickly

Contact your neurologist's office immediately when you receive an additional information request. Many practices have dedicated prior authorization coordinators who can submit responses within 24-48 hours.

Note: Counterforce Health specializes in helping patients navigate complex prior authorization requirements like these. Their platform can help identify exactly what documentation Cigna needs and draft targeted responses that address specific denial reasons.

Decision Window and Outcomes

Typical Approval Outcomes

Approved for 1 Year: Most common outcome when all criteria are met. Cigna approves Kesimpta for 12-month periods for patients meeting their clinical criteria.

Conditional Approval: May require specific pharmacy (Accredo), quantity limits, or additional monitoring requirements.

Denial: Common reasons include missing specialist involvement, incomplete safety screening, or non-relapsing MS diagnosis.

Reading Your Approval Letter

Your approval letter will specify:

  • Authorization period (typically 1 year)
  • Quantity limits (usually 1 pen per month after initial loading doses)
  • Designated specialty pharmacy (often Accredo)
  • NDC codes covered under the authorization

If Denied: New Jersey Appeal Process

New Jersey offers one of the strongest patient appeal systems in the country through the Independent Health Care Appeals Program (IHCAP).

Internal Appeals with Cigna

Level 1 Appeal:

  • Deadline: 180 days from denial date
  • Timeline: 30 days for standard review, 15 days for expedited
  • Who can file: Patient, authorized representative, or provider with consent

Level 2 Appeal:

  • Automatic: If Level 1 is denied
  • Timeline: 30 days for decision

External Review Through IHCAP

After completing internal appeals, you can pursue independent review through New Jersey's IHCAP program:

  • Success rate: Approximately 50% of appeals favor consumers
  • Cost: Free (insurers pay all review costs)
  • Timeline: 45 days for standard review, 72 hours for expedited
  • Filing deadline: 180 days from final Cigna denial
  • Contact: 1-888-393-1062 or online application
  • Administered by: Maximus Federal Services

Required Documentation for IHCAP:

  • Final denial letter from Cigna
  • All internal appeal correspondence
  • Complete medical records supporting medical necessity
  • Provider letter explaining why Kesimpta is medically necessary
From our advocates: We've seen many New Jersey patients succeed with IHCAP appeals when they include detailed neurologist letters explaining why Kesimpta's unique monthly dosing and efficacy profile is specifically needed for their MS progression pattern. The independent physician reviewers often understand nuances that insurance company algorithms miss.

Annual Renewal Cycles

When to Initiate Renewal

Start the renewal process 60-90 days before your current authorization expires. Cigna approves renewals for additional 1-year periods when patients demonstrate continued medical necessity.

Renewal Documentation Requirements

For patients on Kesimpta for 1+ years, Cigna requires evidence of:

  • Continued relapsing MS diagnosis
  • Ongoing specialist care
  • Clinical stability or improvement
  • Absence of serious adverse effects

Clinical Measures That Support Renewal:

  • Stable or improved MRI findings
  • Reduced relapse frequency
  • Maintained or improved EDSS scores
  • Good tolerability profile

Timeline Visual and Milestones

Milestone Timeline Key Actions Success Factors
Pre-submission 0-2 days Gather documentation, complete labs Complete safety screening
Initial submission Day 1 Neurologist submits PA Electronic submission preferred
Cigna review 1-5 days Utilization management review Complete documentation package
Additional info 1-7 days Respond to requests 3-day response deadline
Decision 5-9 days Approval/denial notification Most approvals within 5 days
Appeal (if needed) 30 days Internal appeal process Strong clinical justification
IHCAP review 45 days External independent review 50% success rate

Time-Saving Tips for Faster Approval

Portal Usage Optimization

  • Use electronic systems: CoverMyMeds and Cigna's provider portal process requests faster than fax submissions
  • Submit complete packages: Include all required documentation in the initial submission
  • Follow up proactively: Check portal status every 2-3 business days

Bundled Evidence Strategy

  • Comprehensive medical necessity letter: Have your neurologist include diagnosis details, treatment history, and specific rationale for Kesimpta
  • Supporting guidelines: Reference FDA labeling and MS society treatment guidelines
  • Clinical measurements: Include objective measures like MRI progression and relapse frequency

Direct Specialty Routing

  • Coordinate with Accredo: Contact Accredo directly once approved to expedite fulfillment
  • Verify pharmacy benefits: Confirm Kesimpta coverage under your specific Cigna plan's specialty tier

Common Denial Reasons and Solutions

Denial Reason Solution Required Documentation
Non-relapsing MS diagnosis Clarify MS phenotype Updated neurologist letter confirming relapsing pattern
Missing specialist involvement Add neurologist consultation Referral or consultation notes from MS specialist
Incomplete safety screening Submit all required labs HBV screening, CBC, liver function tests
Age requirement Verify patient age Birth date confirmation (automatic for patients 18+)
Overlapping DMTs Document therapy transition Timeline showing discontinuation of prior DMT

Costs and Patient Assistance

Insurance Coverage

Kesimpta is typically covered under Cigna's specialty pharmacy benefit with copays ranging from $10-50/month for most commercial plans, depending on your specific benefit design.

Manufacturer Support

  • Kesimpta Connect: Novartis offers copay assistance up to $5,000 annually for eligible commercial insurance patients
  • Patient assistance program: Free medication for qualifying uninsured patients
  • Appeals support: Coverage assistance through Kesimpta Connect during appeals

State Resources

New Jersey residents can contact:

  • NJ Department of Banking and Insurance: 1-800-446-7467 for insurance complaints
  • IHCAP Hotline: 1-888-393-1062 for external review assistance

FAQ

How long does Cigna prior authorization take for Kesimpta in New Jersey? Cigna typically responds within 5 business days. New Jersey law requires decisions within 9 calendar days for non-urgent requests (effective 2025) and 72 hours for urgent cases.

What if Kesimpta is non-formulary on my Cigna plan? You can request a formulary exception through Cigna's appeals process. Provide clinical documentation showing medical necessity and why formulary alternatives are inappropriate.

Can I request expedited review for Kesimpta? Yes, if your condition seriously jeopardizes your health or ability to regain function. Your neurologist must document the urgent medical necessity for 24-hour review.

Does step therapy apply if I've tried other MS drugs outside New Jersey? Prior therapy trials from other states should count toward step therapy requirements. Ensure your neurologist documents all previous MS treatments and outcomes.

What happens if my renewal is denied? You can appeal renewal denials through the same process as initial denials. Many patients receive temporary medication supplies through manufacturer programs during appeals.

How much does Kesimpta cost with Cigna coverage? Costs vary by plan, but most commercial Cigna plans cover Kesimpta under specialty pharmacy benefits with copays typically $10-50/month after meeting deductibles.

Counterforce Health helps patients navigate these complex coverage challenges by analyzing denial letters and crafting evidence-based appeals that address specific payer requirements. Their platform can identify the exact documentation needed for your Cigna appeal and help draft targeted responses that improve approval odds.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions vary by individual circumstances and plan details. Always consult with your healthcare provider and insurance plan directly for specific coverage questions. For assistance with complex prior authorization and appeals, visit Counterforce Health to learn how their platform helps patients get prescription drugs approved through evidence-based appeals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.